PCRX — Pacira Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Pacira Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	656	289	279	485	238
Net Total Accounts Receivable
Net Total Receivables	96.3	98.4	106	113	124
Total Inventory
Prepaid Expenses
Total Current Assets	866	498	510	745	548
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	265	254	235	216	182
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,075	1,681	1,574	1,554	1,265
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	521	148	97.4	310	121
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	1,345	906	704	775	572
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	730	775	870	778	693
Total Liabilities & Shareholders' Equity	2,075	1,681	1,574	1,554	1,265
Total Common Shares Outstanding